Literature DB >> 19036020

Treosulphan as an alternative to busulphan for myeloablative conditioning in paediatric allogeneic transplantation.

Rob Cutting, Anna Mirelman, Ajay Vora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19036020     DOI： 10.1111/j.1365-2141.2008.07399.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

Review 1.  Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms.

Authors:  Aravind Ramakrishnan; Brenda M Sandmaier
Journal:  Expert Rev Hematol       Date:  2010-02-01       Impact factor: 2.929

2.  Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.

Authors:  Eneida R Nemecek; Katherine A Guthrie; Mohamed L Sorror; Brent L Wood; Kristine C Doney; Ralf A Hilger; Bart L Scott; Tibor J Kovacsovics; Richard T Maziarz; Ann E Woolfrey; Antonio Bedalov; Jean E Sanders; John M Pagel; Eileen J Sickle; Robert Witherspoon; Mary E Flowers; Frederick R Appelbaum; H Joachim Deeg
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-26       Impact factor: 5.742

3.  Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.

Authors:  Tapani Ruutu; Liisa Volin; Dietrich W Beelen; Rudolf Trenschel; Juergen Finke; Marc Schnitzler; Jerzy Holowiecki; Sebastian Giebel; Miroslaw Markiewicz; Lutz Uharek; Igor W Blau; Joachim Kienast; Matthias Stelljes; Kajsa Larsson; Axel R Zander; Martin Gramatzki; Roland Repp; Hermann Einsele; Gernot Stuhler; Joachim Baumgart; Heidrun A Mylius; Uwe Pichlmeier; Mathias Freund; Jochen Casper
Journal:  Haematologica       Date:  2011-06-09       Impact factor: 9.941

4.  Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases.

Authors:  M A Slatter; H Boztug; U Pötschger; K-W Sykora; A Lankester; I Yaniv; P Sedlacek; E Glogova; P Veys; A R Gennery; C Peters
Journal:  Bone Marrow Transplant       Date:  2015-08-10       Impact factor: 5.483

Review 5.  Treosulfan-based conditioning for inborn errors of immunity.

Authors:  Mary A Slatter; Andrew R Gennery
Journal:  Ther Adv Hematol       Date:  2021-05-20

Review 6.  Total Body Irradiation Forever? Optimising Chemotherapeutic Options for Irradiation-Free Conditioning for Paediatric Acute Lymphoblastic Leukaemia.

Authors:  Khalil Ben Hassine; Madeleine Powys; Peter Svec; Miroslava Pozdechova; Birgitta Versluys; Marc Ansari; Peter J Shaw
Journal:  Front Pediatr       Date:  2021-12-10       Impact factor: 3.418
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.